Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2026

Conditions
Degenerative Disc DiseaseSpondylolisthesis
Interventions
DEVICE

NB1

rhNELL-1/DBX

Trial Locations (3)

3168

RECRUITING

Monash Medical Center, Clayton

Unknown

RECRUITING

St Vincent Melbourne, Fitzroy

RECRUITING

St George Hospital, Kogarah

Sponsors
All Listed Sponsors
lead

Bone Biologics Corp

INDUSTRY

NCT03810573 - Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis | Biotech Hunter | Biotech Hunter